Works by Sakamoto, Junichi


Results: 247
    1
    2

    A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study).

    Published in:
    2016
    By:
    • Shoichi Hazama;
    • Hiromichi Maeda;
    • Shigeyoshi Iwamoto;
    • Ho Min Kim;
    • Hiroyoshi Takemoto;
    • Kenji Kobayashi;
    • Junichi Sakamoto;
    • Naoki Nagata;
    • Koji Oba;
    • Hideyuki Mishima;
    • Hazama, Shoichi;
    • Maeda, Hiromichi;
    • Iwamoto, Shigeyoshi;
    • Kim, Ho Min;
    • Takemoto, Hiroyoshi;
    • Kobayashi, Kenji;
    • Sakamoto, Junichi;
    • Nagata, Naoki;
    • Oba, Koji;
    • Mishima, Hideyuki
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8

    Daikenchuto accelerates the recovery from prolonged postoperative ileus after open abdominal surgery: a subgroup analysis of three randomized controlled trials.

    Published in:
    Surgery Today, 2019, v. 49, n. 8, p. 704, doi. 10.1007/s00595-019-01787-9
    By:
    • Kono, Toru;
    • Shimada, Mitsuo;
    • Nishi, Masaaki;
    • Morine, Yuji;
    • Yoshikawa, Kozo;
    • Katsuno, Hidetoshi;
    • Maeda, Koutarou;
    • Koeda, Keisuke;
    • Morita, Satoshi;
    • Watanabe, Masahiko;
    • Kusano, Mitsuo;
    • Sakamoto, Junichi;
    • Saji, Shigetoyo;
    • Sokuoka, Hiroki;
    • Sato, Yasuto;
    • Maehara, Yoshihiko;
    • Kanematsu, Takashi;
    • Kitajima, Masaki
    Publication type:
    Article
    9
    10

    Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study Group

    Published in:
    Oncology, 2018, v. 94, n. 2, p. 85, doi. 10.1159/000481945
    By:
    • Takaku, Tomoiku;
    • Iriyama, Noriyoshi;
    • Mitsumori, Toru;
    • Sato, Eriko;
    • Gotoh, Akihiko;
    • Kirito, Keita;
    • Noguchi, Masaaki;
    • Koike, Michiaki;
    • Sakamoto, Junichi;
    • Oba, Koji;
    • Komatsu, Norio
    Publication type:
    Article
    11
    12
    13
    14

    Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study).

    Published in:
    2019
    By:
    • Nagata, Naoki;
    • Maeda, Hiromichi;
    • Ishibashi, Keiichiro;
    • Hirata, Keiji;
    • Makiyama, Akitaka;
    • Iwamoto, Shigeyoshi;
    • Takemoto, Hiroyoshi;
    • Imasato, Mitsunobu;
    • Yoshida, Yoichiro;
    • Munemoto, Yoshinori;
    • Tanaka, Chihiro;
    • Morita, Yoshitaka;
    • Hotta, Yoshihiro;
    • Toyofuku, Atsushi;
    • Nagasaka, Takeshi;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Mishima, Hideyuki
    Publication type:
    journal article
    15

    No Significant Effect of Daikenchuto (TJ-100) on Peritoneal IL-9 and IFN-γ Levels After Pancreaticoduodenectomy.

    Published in:
    Clinical & Experimental Gastroenterology, 2020, v. 13, p. 461, doi. 10.2147/CEG.S262082
    By:
    • Maeda, Hiromichi;
    • Okada, Ken-ichi;
    • Fujii, Tsutomu;
    • Oba, Mari S;
    • Kawai, Manabu;
    • Hirono, Seiko;
    • Kodera, Yasuhiro;
    • Sho, Masayuki;
    • Akahori, Takahiro;
    • Shimizu, Yasuhiro;
    • Ambo, Yoshiyasu;
    • Kondo, Naru;
    • Murakami, Yoshiaki;
    • Ohuchida, Jiro;
    • Eguchi, Hidetoshi;
    • Nagano, Hiroaki;
    • Sakamoto, Junichi;
    • Yamaue, Hiroki
    Publication type:
    Article
    16

    WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient.

    Published in:
    European Journal of Haematology, 2010, v. 85, n. 4, p. 358, doi. 10.1111/j.1600-0609.2010.01497.x
    By:
    • Oji, Yusuke;
    • Oka, Yoshihiro;
    • Nishida, Sumiyuki;
    • Tsuboi, Akihiro;
    • Kawakami, Manabu;
    • Shirakata, Toshiaki;
    • Takahashi, Kazuko;
    • Murao, Ayako;
    • Nakajima, Hiroko;
    • Narita, Miwako;
    • Takahashi, Masuhiro;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Tanaka, Toshio;
    • Kawase, Ichiro;
    • Hosen, Naoki;
    • Sugiyama, Haruo
    Publication type:
    Article
    17

    Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B.

    Published in:
    Breast Cancer (13406868), 2013, v. 20, n. 2, p. 131, doi. 10.1007/s12282-011-0316-z
    By:
    • Hayashi, Hidetoshi;
    • Tsurutani, Junji;
    • Satoh, Taro;
    • Masuda, Norikazu;
    • Okamoto, Wataru;
    • Morinaga, Ryotaro;
    • Terashima, Masaaki;
    • Miyazaki, Masaki;
    • Okamoto, Isamu;
    • Nishida, Yukihiro;
    • Tominaga, Shusei;
    • Tokunaga, Yukihiko;
    • Yamaguchi, Masahide;
    • Sakamoto, Junichi;
    • Nakayama, Takahiro;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    18
    19

    Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia.

    Published in:
    International Journal of Hematology, 2014, v. 99, n. 1, p. 41, doi. 10.1007/s12185-013-1483-9
    By:
    • Kumagai, Takashi;
    • Matsuki, Eri;
    • Inokuchi, Koiti;
    • Ohashi, Kazuteru;
    • Shinagawa, Atsushi;
    • Takeuchi, Jin;
    • Yoshida, Chikashi;
    • Okamoto, Shinichiro;
    • Wakita, Hisashi;
    • Kozai, Yasuji;
    • Shirasugi, Yukari;
    • Fujisawa, Shin;
    • Iwase, Osamu;
    • Yano, Shingo;
    • Nishiwaki, Kaichi;
    • Oba, Koji;
    • Sakamoto, Junichi;
    • Sakamaki, Hisashi
    Publication type:
    Article
    20

    Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma.

    Published in:
    2007
    By:
    • Tsuboi, Akihiro;
    • Oka, Yoshihiro;
    • Nakajima, Hiroko;
    • Fukuda, Yoko;
    • Elisseeva, Olga A;
    • Yoshihara, Satoshi;
    • Hosen, Naoki;
    • Ogata, Atsushi;
    • Kito, Katsuyuki;
    • Fujiki, Fumihiro;
    • Nishida, Sumiyuki;
    • Shirakata, Toshiaki;
    • Ohno, Satoshi;
    • Yasukawa, Masaki;
    • Oji, Yusuke;
    • Kawakami, Manabu;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Udaka, Keiko;
    • Kawase, Ichiro
    Publication type:
    journal article
    21
    22
    23

    Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.

    Published in:
    2019
    By:
    • Tomita, Naohiro;
    • Kunieda, Katsuyuki;
    • Maeda, Atsuyuki;
    • Hamada, Chikuma;
    • Yamanaka, Takeharu;
    • Sato, Toshihiko;
    • Yoshida, Kazuhiro;
    • Boku, Narikazu;
    • Nezu, Riichiro;
    • Yamaguchi, Shigeki;
    • Mishima, Hideyuki;
    • Sadahiro, Sotaro;
    • Muro, Kei;
    • Ishiguro, Megumi;
    • Sakamoto, Junichi;
    • Saji, Shigetoyo;
    • Maehara, Yoshihiko
    Publication type:
    journal article
    24
    25

    Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer.

    Published in:
    Cancer Science, 2021, v. 112, n. 11, p. 4669, doi. 10.1111/cas.15092
    By:
    • Satoru Iwasa;
    • Kei Muro;
    • Satoshi Morita;
    • Young Suk Park;
    • Masato Nakamura;
    • Masahito Kotaka;
    • Tomohiro Nishina;
    • Hiroshi Matsuoka;
    • Joong Bae Ahn;
    • Keun-Wook Lee;
    • Yong Sang Hong;
    • Sae Won Han;
    • Sang-Hee Cho;
    • Dong-Sheng Zhang;
    • Wei-Jia Fang;
    • Li Bai;
    • Xiang-Lin Yuan;
    • Ying Yuan;
    • Yasuhide Yamada;
    • Junichi Sakamoto
    Publication type:
    Article
    26

    Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission.

    Published in:
    Cancer Science, 2020, v. 111, n. 8, p. 2923, doi. 10.1111/cas.14518
    By:
    • Kumagai, Takashi;
    • Nakaseko, Chiaki;
    • Nishiwaki, Kaichi;
    • Yoshida, Chikashi;
    • Ohashi, Kazuteru;
    • Takezako, Naoki;
    • Takano, Hina;
    • Kouzai, Yasuji;
    • Murase, Tadashi;
    • Matsue, Kosei;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Wakita, Hisashi;
    • Sakamaki, Hisashi;
    • Inokuchi, Koiti
    Publication type:
    Article
    27

    Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation.

    Published in:
    Cancer Science, 2018, v. 109, n. 1, p. 182, doi. 10.1111/cas.13430
    By:
    • Kumagai, Takashi;
    • Nakaseko, Chiaki;
    • Nishiwaki, Kaichi;
    • Yoshida, Chikashi;
    • Ohashi, Kazuteru;
    • Takezako, Naoki;
    • Takano, Hina;
    • Kouzai, Yasuji;
    • Murase, Tadashi;
    • Matsue, Kosei;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Wakita, Hisashi;
    • Sakamaki, Hisashi;
    • Inokuchi, Koiti;
    • the Kanto CML and Shimousa Hematology Study Groups
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34

    Expression of Lewis.

    Published in:
    Journal of Surgical Oncology, 1990, v. 44, n. 4, p. 208, doi. 10.1002/jso.2930440404
    By:
    • Inagaki, Hiroshi;
    • Sakamoto, Junichi;
    • Nakazato, Hiroaki;
    • Bishop, Anne E.;
    • Yura, Jiro
    Publication type:
    Article
    35
    36
    37
    38
    39
    40

    Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 9, p. 819, doi. 10.1002/ajh.24096
    By:
    • Iriyama, Noriyoshi;
    • Fujisawa, Shin;
    • Yoshida, Chikashi;
    • Wakita, Hisashi;
    • Chiba, Shigeru;
    • Okamoto, Shinichiro;
    • Kawakami, Kimihiro;
    • Takezako, Naoki;
    • Kumagai, Takashi;
    • Inokuchi, Koiti;
    • Ohyashiki, Kazuma;
    • Taguchi, Jun;
    • Yano, Shingo;
    • Igarashi, Tadahiko;
    • Kouzai, Yasuji;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Sakamaki, Hisashi
    Publication type:
    Article
    41

    Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 4, p. 282, doi. 10.1002/ajh.23923
    By:
    • Iriyama, Noriyoshi;
    • Fujisawa, Shin;
    • Yoshida, Chikashi;
    • Wakita, Hisashi;
    • Chiba, Shigeru;
    • Okamoto, Shinichiro;
    • Kawakami, Kimihiro;
    • Takezako, Naoki;
    • Kumagai, Takashi;
    • Inokuchi, Koiti;
    • Ohyashiki, Kazuma;
    • Taguchi, Jun;
    • Yano, Shingo;
    • Igarashi, Tadahiko;
    • Kouzai, Yasuji;
    • Morita, Satoshi;
    • Sakamoto, Junichi;
    • Sakamaki, Hisashi
    Publication type:
    Article
    42

    Study of Low-Dose Capecitabine Monotherapy for Metastatic Breast Cancer.

    Published in:
    Chemotherapy (0009-3157), 2010, v. 56, n. 2, p. 166, doi. 10.1159/000313531
    By:
    • Taguchi, Tetsuya;
    • Nakayama, Takahiro;
    • Masuda, Norikazu;
    • Yoshidome, Katsuhide;
    • Akagi, Kenzou;
    • Nishida, Yukihiro;
    • Yoshikawa, Yukinobu;
    • Ogino, Nobuo;
    • Abe, Chigusa;
    • Sakamoto, Junichi;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    43
    44
    45

    Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

    Published in:
    Cancer Medicine, 2020, v. 9, n. 24, p. 9419, doi. 10.1002/cam4.3564
    By:
    • Ooki, Akira;
    • Morita, Satoshi;
    • Tsuji, Akihito;
    • Iwamoto, Shigeyoshi;
    • Hara, Hiroki;
    • Tanioka, Hiroaki;
    • Satake, Hironaga;
    • Kataoka, Masato;
    • Kotaka, Masahito;
    • Kagawa, Yoshinori;
    • Nakamura, Masato;
    • Shingai, Tatsushi;
    • Ishikawa, Masashi;
    • Miyake, Yasuhiro;
    • Suto, Takeshi;
    • Hashiguchi, Yojiro;
    • Yabuno, Taichi;
    • Ando, Masahiko;
    • Sakamoto, Junichi;
    • Yamaguchi, Kensei
    Publication type:
    Article
    46

    Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 5, p. 1779, doi. 10.1002/cam4.2826
    By:
    • Ooki, Akira;
    • Morita, Satoshi;
    • Iwamoto, Shigeyoshi;
    • Hara, Hiroki;
    • Tanioka, Hiroaki;
    • Satake, Hironaga;
    • Kataoka, Masato;
    • Kotaka, Masahito;
    • Kagawa, Yoshinori;
    • Nakamura, Masato;
    • Shingai, Tatsushi;
    • Ishikawa, Masashi;
    • Miyake, Yasuhiro;
    • Suto, Takeshi;
    • Hashiguchi, Yojiro;
    • Yabuno, Taichi;
    • Sakamoto, Junichi;
    • Tsuji, Akihito;
    • Ando, Masahiko;
    • Yamaguchi, Kensei
    Publication type:
    Article
    47

    A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial.

    Published in:
    Cancer Medicine, 2018, v. 7, n. 9, p. 4217, doi. 10.1002/cam4.1623
    By:
    • Iwamoto, Shigeyoshi;
    • Ooki, Akira;
    • Morita, Satoshi;
    • Hara, Hiroki;
    • Tanioka, Hiroaki;
    • Satake, Hironaga;
    • Kataoka, Masato;
    • Kotaka, Masahito;
    • Kagawa, Yoshinori;
    • Nakamura, Masato;
    • Shingai, Tatsushi;
    • Ishikawa, Masashi;
    • Miyake, Yasuhiro;
    • Sudo, Takeshi;
    • Hashiguchi, Yojiro;
    • Yabuno, Taichi;
    • Sakamoto, Junichi;
    • Tsuji, Akihito;
    • Ando, Masahiko;
    • Yamaguchi, Kensei
    Publication type:
    Article
    48
    49
    50

    Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0245-1
    By:
    • Soekojo, Cinnie Yentia;
    • Kim, Kihyun;
    • Huang, Shang-Yi;
    • Chim, Chor-Sang;
    • Takezako, Naoki;
    • Asaoku, Hideki;
    • Kimura, Hideo;
    • Kosugi, Hiroshi;
    • Sakamoto, Junichi;
    • Gopalakrishnan, Sathish Kumar;
    • Nagarajan, Chandramouli;
    • Wei, Yuan;
    • Moorakonda, Rajesh;
    • Lee, Shu Ling;
    • Lee, Je Jung;
    • Yoon, Sung-Soo;
    • Kim, Jin Seok;
    • Min, Chang Ki;
    • Lee, Jae-Hoon;
    • Durie, Brian
    Publication type:
    Article